INTEGRATE: The Endoscopic Assesment of Intestinal Grafts

Sponsor
Sahlgrenska University Hospital, Sweden (Other)
Overall Status
Recruiting
CT.gov ID
NCT03444675
Collaborator
Sahlgrenska University Hospital, Gothenburg, Sweden (Other), Favaloro Foundation University Hospital, Buenos Aires, Argentina (Other), MedStar Georgetown University Hospital, Washington DC (Other), Hospital Universitario La Paz (Other)
80
4
108.1
20
0.2

Study Details

Study Description

Brief Summary

The study validates prospectively a new endoscopic scoring system (Gothenburg Intestinal Transplant Endoscopy Score, GITES) designed to summarize and stratify the abnormal ileal endoscopic findings after intestinal transplantation. GITES is a five-tier, four grade score which asseses mucosal friability, mucosal erythema and mucosal injury (ulcerations) as well as villous changes according to severity. These features (i.e., endoscopic descriptors) are also grouped from mild to very severe in the same sequence as observed during the progression of several pathologic conditions encountered after intestinal transplantation (acute rejection, infectious enteritis).

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Multi-centre, Longitudinal (Cohort) Study in Patients Undergoing Intestinal or Multivisceral Transplantation to Validate Gothenburg Intestinal Transplant Endoscopy Score (GITES) and Evaluate Its Clinical Performance
Actual Study Start Date :
Apr 29, 2014
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
May 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Endoscopic evaluation [7 years]

    To validate the GITES grading system in intestinal graft recipients using high-definition white light endoscopy

Secondary Outcome Measures

  1. Correlations with histology and Clinical course [1 year]

    Comparison and correlation of clinical and histopathological data with endoscopic findings to evaluate the conditions leading to the mucosal alterations defined by established endoscopic descriptors and GITES.

  2. Performance of the grading score [1 year]

    Endpoints include sensitivity, specificity, positive predictive value, negative predictive value as well as inter- and intraobserver variation in the evaluation of the mucosal alterations by means of GITES and using high-definition white light endoscopy;

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • transplantation of a segment of small intestine (as isolated graft or together with other organs)
Exclusion Criteria:
  • contraindications for ileoscopy

Contacts and Locations

Locations

Site City State Country Postal Code
1 MedStar Georgetown University Hospital Washington District of Columbia United States 20007
2 Favaloro Foundation University Hospital Buenos Aires Argentina C1093AAS
3 Hospital Universitario "La Paz" Madrid Spain
4 Sahlgrenska University Hospital Gothenburg Sweden 41345

Sponsors and Collaborators

  • Sahlgrenska University Hospital, Sweden
  • Sahlgrenska University Hospital, Gothenburg, Sweden
  • Favaloro Foundation University Hospital, Buenos Aires, Argentina
  • MedStar Georgetown University Hospital, Washington DC
  • Hospital Universitario La Paz

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mihai Oltean, Dr., Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT03444675
Other Study ID Numbers:
  • GBG18001
First Posted:
Feb 23, 2018
Last Update Posted:
May 15, 2020
Last Verified:
May 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mihai Oltean, Dr., Sahlgrenska University Hospital, Sweden
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 15, 2020